Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bausch Health Companies Inc BHC


Primary Symbol: T.BHC

Healthcare
Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with... see more

Recent & Breaking News (TSX:BHC)

Bausch Health Commences Cash Tender Offer For Any And All Of Its 7.00% Senior Secured Notes Due 2024

PR Newswire May 24, 2021

Bausch Health Announces Launch Of Private Offering Of Senior Secured Notes And Conditional Redemption Of Existing Senior Secured Notes

Canada NewsWire May 24, 2021

Salix Will Feature New Data At Digestive Disease Week® 2021

PR Newswire May 17, 2021

New National Eye Institute Data Shows AREDS2 Nutrient Formula Continues To Reduce The Risk Of Moderate To Advanced Age-Related Macular Degeneration Progression

Canada NewsWire May 11, 2021

Bausch Health Announces Participation In Upcoming Investor Conferences

Canada NewsWire May 6, 2021

Health Canada Issues Notice of Compliance (NOC) for Bausch Health's BRYHALI(TM)

Canada NewsWire May 5, 2021

Bausch Health Companies Inc. Announces First-Quarter 2021 Results

Canada NewsWire May 4, 2021

Clearside Biomedical Announces Resubmission of New Drug Application for XIPERE(TM) for Treatment of Macular Edema Associated with Uveitis

GlobeNewswire May 3, 2021

Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations

Canada NewsWire May 3, 2021

Bausch + Lomb Will Present New Scientific Data And Analyses On Products And Pipeline Programs During The Association For Research In Vision And Ophthalmology Meeting

Canada NewsWire April 29, 2021

Bausch Health Announces 2021 Annual Meeting of Shareholder Results

PR Newswire April 28, 2021

Bausch Health Issues Form 8-K for 2021 Annual Meeting of Shareholders Presentation

Canada NewsWire April 27, 2021

Ortho Dermatologics Announces Statistically Significant Topline Results From Second Pivotal Phase 3 Clinical Trial Evaluating IDP-126 Gel In Acne Vulgaris

Canada NewsWire April 22, 2021

Ortho Dermatologics to Present New Data at the 2021 American Academy of Dermatology Annual Meeting

Canada NewsWire April 21, 2021

New Report Reveals That More Than One-Third Of IBS Patients Surveyed State It Has Been More Challenging To Manage Their Symptoms During The COVID-19 Pandemic

Canada NewsWire April 15, 2021

Bausch + Lomb Announces Statistically Significant Topline Results From The First Phase 3 Trial Of NOV03 (perfluorohexyloctane) In Dry Eye Disease Associated With Meibomian Gland Dysfunction

Canada NewsWire April 13, 2021

Bausch Health Companies Inc. Will Release First-Quarter 2021 Financial Results On May 4

Canada NewsWire April 9, 2021

Bausch Health Launches ENVIVE(TM) Daily Probiotic Supplement

PR Newswire April 8, 2021

FDA Approves Bausch + Lomb ClearVisc(TM) Dispersive Ophthalmic Viscosurgical Device

Canada NewsWire April 7, 2021

Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations

PR Newswire April 7, 2021